CLINICAL_TRIALS
trial_result
· 2022-11-02
Clinical Trial Update: EpiCeram for Skin Protection in Healthcare Workers [NA]
Summary
A terminated clinical trial evaluated EpiCeram for protection against irritant contact dermatitis in healthcare workers; results were posted in November 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Primus Pharmaceuticals | Conditions: Irritant Contact Dermatitis | NA | Status: TERMINATED | Results posted: 2022-11-02